vs
T Stamp Inc（IDAI）与Prime Medicine, Inc.（PRME）财务数据对比。点击上方公司名可切换其他公司
T Stamp Inc的季度营收约是Prime Medicine, Inc.的1.1倍（$908.9K vs $838.0K），T Stamp Inc净利率更高（-279.9% vs -5498.7%，领先5218.8%），T Stamp Inc同比增速更快（-39.3% vs -61.6%），T Stamp Inc自由现金流更多（$2.0M vs $-37.5M）
T Stamp Inc（股票代码IDAI）研发并提供AI驱动的身份核验、信任评分与欺诈防护解决方案，服务覆盖金融科技、医疗健康、电商等领域，主要面向北美市场客户，助力企业安全验证用户身份、降低欺诈风险。
Prime Medicine, Inc.是一家总部位于美国马萨诸塞州剑桥的生物科技企业，核心业务是依托先导编辑技术开发新型基因治疗方案，致力于为遗传病等相关疾病探索创新治疗手段，推动前沿基因编辑技术的临床转化与应用。
IDAI vs PRME — 直观对比
营收规模更大
IDAI
是对方的1.1倍
$838.0K
营收增速更快
IDAI
高出22.3%
-61.6%
净利率更高
IDAI
高出5218.8%
-5498.7%
自由现金流更多
IDAI
多$39.5M
$-37.5M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $908.9K | $838.0K |
| 净利润 | $-2.5M | $-46.1M |
| 毛利率 | — | — |
| 营业利润率 | -224.9% | -5800.5% |
| 净利率 | -279.9% | -5498.7% |
| 营收同比 | -39.3% | -61.6% |
| 净利润同比 | 57.7% | -9.0% |
| 每股收益（稀释后） | $-0.37 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDAIPRME
| Q4 25 | $908.9K | $838.0K | ||
| Q3 25 | $872.5K | $1.2M | ||
| Q2 25 | $812.7K | $1.1M | ||
| Q1 25 | $545.5K | $1.5M | ||
| Q4 24 | $1.5M | $2.2M | ||
| Q3 24 | $511.1K | — | ||
| Q2 24 | $500.4K | $0 | ||
| Q1 24 | $573.7K | $591.0K |
净利润IDAIPRME
| Q4 25 | $-2.5M | $-46.1M | ||
| Q3 25 | $-1.9M | $-50.6M | ||
| Q2 25 | $-1.7M | $-52.6M | ||
| Q1 25 | $-2.2M | $-51.9M | ||
| Q4 24 | $-6.0M | $-42.3M | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | $-2.6M | $-55.3M | ||
| Q1 24 | $-2.7M | $-45.8M |
营业利润率IDAIPRME
| Q4 25 | -224.9% | -5800.5% | ||
| Q3 25 | -203.0% | -4406.0% | ||
| Q2 25 | -207.0% | -4787.2% | ||
| Q1 25 | -396.5% | -3603.3% | ||
| Q4 24 | -81.2% | -2025.7% | ||
| Q3 24 | -523.7% | — | ||
| Q2 24 | -524.7% | — | ||
| Q1 24 | -496.7% | -8179.5% |
净利率IDAIPRME
| Q4 25 | -279.9% | -5498.7% | ||
| Q3 25 | -219.1% | -4129.1% | ||
| Q2 25 | -210.7% | -4716.7% | ||
| Q1 25 | -395.5% | -3568.8% | ||
| Q4 24 | -401.5% | -1936.6% | ||
| Q3 24 | -245.7% | — | ||
| Q2 24 | -519.3% | — | ||
| Q1 24 | -466.9% | -7743.0% |
每股收益（稀释后）IDAIPRME
| Q4 25 | $-0.37 | $-0.22 | ||
| Q3 25 | $-0.72 | $-0.32 | ||
| Q2 25 | $-0.69 | $-0.41 | ||
| Q1 25 | $-0.89 | $-0.40 | ||
| Q4 24 | $-3.14 | $-0.31 | ||
| Q3 24 | $-1.06 | — | ||
| Q2 24 | $-3.19 | $-0.46 | ||
| Q1 24 | $-3.97 | $-0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $63.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $8.7M | $120.9M |
| 总资产 | $11.2M | $342.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IDAIPRME
| Q4 25 | $6.0M | $63.0M | ||
| Q3 25 | $5.4M | $71.4M | ||
| Q2 25 | $292.1K | $53.8M | ||
| Q1 25 | $1.1M | $91.9M | ||
| Q4 24 | $2.8M | $182.5M | ||
| Q3 24 | $598.0K | — | ||
| Q2 24 | $659.5K | $55.6M | ||
| Q1 24 | $816.7K | $94.2M |
股东权益IDAIPRME
| Q4 25 | $8.7M | $120.9M | ||
| Q3 25 | $6.1M | $161.8M | ||
| Q2 25 | $2.4M | $60.9M | ||
| Q1 25 | $4.1M | $106.9M | ||
| Q4 24 | $3.0M | $153.1M | ||
| Q3 24 | $5.4M | — | ||
| Q2 24 | $750.4K | $196.6M | ||
| Q1 24 | $1.4M | $243.8M |
总资产IDAIPRME
| Q4 25 | $11.2M | $342.7M | ||
| Q3 25 | $11.2M | $385.0M | ||
| Q2 25 | $5.7M | $279.0M | ||
| Q1 25 | $6.6M | $328.2M | ||
| Q4 24 | $8.6M | $297.5M | ||
| Q3 24 | $10.6M | — | ||
| Q2 24 | $5.2M | $259.7M | ||
| Q1 24 | $5.6M | $311.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $-37.3M |
| 自由现金流经营现金流 - 资本支出 | $2.0M | $-37.5M |
| 自由现金流率自由现金流/营收 | 215.4% | -4480.4% |
| 资本支出强度资本支出/营收 | 0.8% | 34.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-5.7M | $-167.1M |
8季度趋势，按日历期对齐
经营现金流IDAIPRME
| Q4 25 | $2.0M | $-37.3M | ||
| Q3 25 | $-4.0M | $-35.0M | ||
| Q2 25 | $-2.1M | $-41.4M | ||
| Q1 25 | $-1.5M | $-48.9M | ||
| Q4 24 | $-2.7M | $16.2M | ||
| Q3 24 | $-2.4M | — | ||
| Q2 24 | $-1.6M | $-45.5M | ||
| Q1 24 | $-2.2M | $-67.7M |
自由现金流IDAIPRME
| Q4 25 | $2.0M | $-37.5M | ||
| Q3 25 | $-4.0M | $-35.3M | ||
| Q2 25 | $-2.1M | $-43.0M | ||
| Q1 25 | $-1.6M | $-51.3M | ||
| Q4 24 | $-2.7M | $14.5M | ||
| Q3 24 | $-2.4M | — | ||
| Q2 24 | $-1.6M | $-47.4M | ||
| Q1 24 | $-2.2M | $-70.0M |
自由现金流率IDAIPRME
| Q4 25 | 215.4% | -4480.4% | ||
| Q3 25 | -459.6% | -2880.5% | ||
| Q2 25 | -258.6% | -3855.1% | ||
| Q1 25 | -289.2% | -3526.8% | ||
| Q4 24 | -182.9% | 662.1% | ||
| Q3 24 | -475.4% | — | ||
| Q2 24 | -320.9% | — | ||
| Q1 24 | -376.6% | -11849.6% |
资本支出强度IDAIPRME
| Q4 25 | 0.8% | 34.6% | ||
| Q3 25 | 0.0% | 20.2% | ||
| Q2 25 | 0.2% | 141.0% | ||
| Q1 25 | 6.8% | 166.6% | ||
| Q4 24 | 0.1% | 82.0% | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 0.5% | 393.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
